Legal troubles for Poonawalla-backed Oxford Covid-19 vaccine
5 years ago 1 min read
A trial participant has sued Poonawalla’s Serum Institute for serious neurological side effects from the trial and demanded Rs5 crore as compensation. The company has counter-sued the trial participant for Rs100 crore.
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push